Research and Development

Over 800 applied research papers

Over 30 years of research

Over 390 publications

Materias primas

Proteínas purificadas

Biotech

Welcome to ROXALL’s Research and Development Department, where innovation drivesour missionto advance allergen immunotherapy.

Our team excelsatoptimizingand creating new allergen extracts, producing highly purified proteinsfor greater product consistency, anddeveloping self-sufficient sources of raw materialssuch as insect venoms, dust mites, and animal dander. Thanks to these efforts, we ensure the highest quality and reliability of our immunotherapy products.

MATERIE PRIME

Production of purified allergen extracts from natural sources and in-house cultures using processes that ensure high quality standards.

EPITHELIAL ANIMAL

EPITHELIAL ANIMAL

We obtain allergen extracts from Felis domesticus (cat) and Canis familiaris (dog) using hair from both species.

ACARI

ACARI

Controlled production of allergenic extracts from various species of mites grown in our own facilities.

VELENI

VELENI

Extraction of venom sacs from hymenopterans and isolation of purified venoms.

MICOFITI

MICOFITI

Cultures of Alternaria alternata and other fungi of allergenic interest, and purification of their major components.

PURIFIED PROTEIN

Purification of the most significant proteins in allergen extracts.

BIOTECH

We are constantly working on other areas of research.

Research on Monoclonal Antibodies for the Detection of Major Allergens

Purification of natural and recombinant proteins forin vitro use

Professional Field

Forgot your password?

Request Access
Request Access

ROXALL Group

You are currently on the ROXALL Italia website.
You can change your location and language settings based on the country you're interested in.

Germania
Austria
Turkey
Spain
Portugal